N. Baxter, Preventive health care, 2001 update: Should women be routinely taught breast self-examination to screen for breast cancer?, CAN MED A J, 164(13), 2001, pp. 1837-1846
Citations number
78
Categorie Soggetti
General & Internal Medicine","Medical Research General Topics
Objectives: To evaluate the evidence relating to the effectiveness of breas
t self-examination (BSE) to screen for breast cancer and to provide recomme
ndations for routine teaching of BSE to women in various age groups as part
of a periodic health examination.
Options: Routine teaching of BSE to women.
Evidence: The electronic databases MEDLINE, PreMEDLINE, CINAHL Health-STAR,
Current Contents and the Cochrane Library were searched for abstracts and
full reports of studies published from 1966 to October 2000 that evaluated
the effectiveness of BSE in reducing breast cancer mortality. In addition,
references of key papers were searched and experts consulted to ensure that
all relevant articles had been identified.
Outcomes: Prevention of death from breast cancer was viewed as the most imp
ortant outcome; other outcomes examined included the stage of cancer detect
ed, the rate of benign biopsy results, the number of patient visits for bre
ast complaints, and psychological benefits and harms.
Values: The recommendations of this report reflect the commitment of the Ca
nadian Task force on Preventive Health Care to provide a structured, eviden
ce-based appraisal of whether a manoeuvre should be included in the periodi
c health examination.
Benefits, harms and costs: Breast cancer is the most frequently diagnosed c
ancer among Canadian women, accounting for 30% of all new cancer cases each
year. In 2000 an estimated 19 200 Canadian women would have been diagnosed
with breast cancer, and 5500 would have died from the disease. To date, 2
large randomized controlled trials, a quasi-randomized trial, a large cohor
t study and several case-control studies have failed to show a benefit for
regular performance of BSE or BSE education, compared with no BSE. In contr
ast, there is good evidence of harm from BSE instruction, including signifi
cant increases in the number of physician visits for the evaluation of beni
gn breast lesions and significantly higher rates of benign biopsy results.
Recommendations:
Women aged 40-49 years: Because there is fair evidence of no benefit, and g
ood evidence of harm, there is fair evidence to recommend that routine teac
hing of BSE be excluded from the periodic health examination of women in th
is age group (grade D recommendation).
Women aged 50-69 years: Because there is fair evidence of no benefit, and g
ood evidence of harm, there is fair evidence to recommend that routine teac
hing of BSE be excluded from the periodic health examination of women in th
is age group (grade D recommendation).
The lack of sufficient evidence to evaulate the effectiveness of the manoeu
vre in women younger than 40 years and those 70 years and older precludes m
aking recommendations for teaching BSE to women in these age groups. The fo
llowing issues may be important to consider: Women younger than 40 years: T
here is little evidence for effectiveness specific to this group. Because t
he incidence of breast cancer is low in this age group, the risk of net har
m from BSE and BSE instruction is even more likely. Women 70 years and olde
r: Although the incidence of breast cancer is high in this group, there is
insufficient evidence to make a recommendation concerning BSE for women 70
years and older.
Important note: Although the evidence indicates no benefit from routine ins
truction, some women will ask to he taught BSE. The potential benefits and
harms should be discussed with the woman, and if BSE is taught, care must b
e taken to ensure she performs BSE in a proficient manner.
Validation: The findings of this analysis were reviewed through an iterativ
e process by the members of the Canadian Task Force on Preventive Health Ca
re. The task force sent the final review and recommendations to 4 independe
nt experts, and their feedback was incorporated in the final draft of the m
anuscript.
Sponsors: The Canadian Task Force an Preventive Health Care is funded throu
gh a partnership between the Provincial and Territorial Ministries of Healt
h and Health Canada.